Proceedings from the society of interventional radiology research consensus panel on critical limb ischemia

Sanjay Misra; Robert Lookstein; John Rundback; Alan T. Hirsch; William R. Hiatt; Michael R. Jaff; Christopher R. White; Michael Conte; Patrick Geraghty; Manesh Patel; Kenneth Rosenfield

doi:10.1016/j.jvir.2012.10.028

Proceedings from the society of interventional radiology research consensus panel on critical limb ischemia

Sanjay Misra, Robert Lookstein, John Rundback, Alan T. Hirsch, William R. Hiatt, Michael R. Jaff, Christopher R. White, Michael Conte, Patrick Geraghty, Manesh Patel, Kenneth Rosenfield

Section of Vascular Surgery

Research output: Contribution to journal › Article › peer-review

4 Scopus citations

Original language	English
Pages (from-to)	451-458
Number of pages	8
Journal	Journal of Vascular and Interventional Radiology
Volume	24
Issue number	4
DOIs	https://doi.org/10.1016/j.jvir.2012.10.028
State	Published - Apr 2013

Access to Document

10.1016/j.jvir.2012.10.028

Cite this

Misra, S., Lookstein, R., Rundback, J., Hirsch, A. T., Hiatt, W. R., Jaff, M. R., White, C. R., Conte, M., Geraghty, P., Patel, M., & Rosenfield, K. (2013). Proceedings from the society of interventional radiology research consensus panel on critical limb ischemia. Journal of Vascular and Interventional Radiology, 24(4), 451-458. https://doi.org/10.1016/j.jvir.2012.10.028

@article{a1649117a4f14327b57f7f9aedd645d7,

title = "Proceedings from the society of interventional radiology research consensus panel on critical limb ischemia",

author = "Sanjay Misra and Robert Lookstein and John Rundback and Hirsch, {Alan T.} and Hiatt, {William R.} and Jaff, {Michael R.} and White, {Christopher R.} and Michael Conte and Patrick Geraghty and Manesh Patel and Kenneth Rosenfield",

note = "Funding Information: This meeting was funded by the SIR Foundation.S.M. received funding from NIH (HL098967, HL109192, HL 88476). He is on the data safety monitoring board for Arteriocyte and Flexstent. R.L. is a consultant for Bayer Interventional, Cordis, and Boston Scientific. J.R. is a consultant for Covidien/ev3, Biotronik, St. Jude, EKOS, Simbionix, and CSI, is a speaker for Boston Scientific, Terumo, and Cook, and received research support from Covidien/ev3, NHLBI/Washington University, SIRtex, Abbott, EKOS, Flexmedics, Aastrom, and CeloNova. A.T.H. received research grants from Abbott Vascular, Aastrom Biosciences, Sanofi-aventis Partnership, Cytokinetics, and Viromed, is on the advisory board of AstraZeneca and Merck, and is a consultant for Novartis, Pozen, Summit Doppler, and Shire HGT. W.R.H. received grant income for trials in peripheral artery disease structured as a contract between the sponsor and CPC Clinical Research (a nonprofit research center affiliated with the University of Colorado) from Aastrom, AstraZeneca, DNAVEC, Pluristem, Takeda, ReNeuron, Tarix and Theravasc. M.R.J. is a consultant for Abbott Vascular (noncompensated), Becker Venture Services Group, Bluegrass Vascular Therapies, Cordis Corporation (noncompensated), Covidien (noncompensated), Hansen Medical, Medtronic (noncompensated), Micell Incorporated, Primacea, Trivascular Inc., and Vortex, and has equity in Access Closure Inc., Embolitech Inc., Hotspur Inc., Icon Interventional Inc., I.C. Sciences Inc., Janacare Inc., Northwind Medical Inc., PQ Bypass Inc., Primacea, Sadra Medical, TMI/Trireme Inc., and Vascular Therapies Inc., is a board member of VIVA Physicians (not for profit), and is a 501(c) 3 Organization member ( www.vivapvd.com ). C.J.W. is a consultant for Baxter Cellular Therapies and is a member of the PAD Guidelines Task Force (ACC/AHA). He is the CARE Steering committee chair (NCDR/ACC) and president of the Society of Cardiovascular Angiography and Interventions (SCAI). M.C. is on the advisory board of Aastrom Biosciences and Humacyte Inc. P.G. is a scientific advisory board member of Bard/Lutonix and Bayer/Medrad. He is an equity holder and has stock options with Pulse Therapeutics. M.P. has research grants with NHBLI, Johnson and Johnson, Astra Zeneca, Baxter Healthcare, and AHRQ and is a consultant and is on the advisory board of Bayer Healthcare, Baxter, Genzyme, Otsuka, and Cardiostem. K.R. is a consultant for Abbott Vascular, Accelmed, Becker Ventures, Micell, Complete Conference Management, Vortex/AngioDynamics, Endospan, Medicines Company, Shockwave Medical, and VuMedi. He has equity in CardioMEMs, Contego, Endospan, Embolitech, Icon, JanaCare, Medical Simulation Corporation, Micell, Primacea, PQ Bypass, Shockwave Medical, and Vortex. He received research or fellowship support from Abbott Vascular, Cordis, Lutonix/Bard, Atrium, and IDEV Technologies. He is a board member of VIVA Physicians ( www.vivapvd.com ). ",

year = "2013",

month = apr,

doi = "10.1016/j.jvir.2012.10.028",

language = "English",

volume = "24",

pages = "451--458",

journal = "Journal of Vascular and Interventional Radiology",

issn = "1051-0443",

number = "4",

}

TY - JOUR

T1 - Proceedings from the society of interventional radiology research consensus panel on critical limb ischemia

AU - Misra, Sanjay

AU - Lookstein, Robert

AU - Rundback, John

AU - Hirsch, Alan T.

AU - Hiatt, William R.

AU - Jaff, Michael R.

AU - White, Christopher R.

AU - Conte, Michael

AU - Geraghty, Patrick

AU - Patel, Manesh

AU - Rosenfield, Kenneth

N1 - Funding Information: This meeting was funded by the SIR Foundation.S.M. received funding from NIH (HL098967, HL109192, HL 88476). He is on the data safety monitoring board for Arteriocyte and Flexstent. R.L. is a consultant for Bayer Interventional, Cordis, and Boston Scientific. J.R. is a consultant for Covidien/ev3, Biotronik, St. Jude, EKOS, Simbionix, and CSI, is a speaker for Boston Scientific, Terumo, and Cook, and received research support from Covidien/ev3, NHLBI/Washington University, SIRtex, Abbott, EKOS, Flexmedics, Aastrom, and CeloNova. A.T.H. received research grants from Abbott Vascular, Aastrom Biosciences, Sanofi-aventis Partnership, Cytokinetics, and Viromed, is on the advisory board of AstraZeneca and Merck, and is a consultant for Novartis, Pozen, Summit Doppler, and Shire HGT. W.R.H. received grant income for trials in peripheral artery disease structured as a contract between the sponsor and CPC Clinical Research (a nonprofit research center affiliated with the University of Colorado) from Aastrom, AstraZeneca, DNAVEC, Pluristem, Takeda, ReNeuron, Tarix and Theravasc. M.R.J. is a consultant for Abbott Vascular (noncompensated), Becker Venture Services Group, Bluegrass Vascular Therapies, Cordis Corporation (noncompensated), Covidien (noncompensated), Hansen Medical, Medtronic (noncompensated), Micell Incorporated, Primacea, Trivascular Inc., and Vortex, and has equity in Access Closure Inc., Embolitech Inc., Hotspur Inc., Icon Interventional Inc., I.C. Sciences Inc., Janacare Inc., Northwind Medical Inc., PQ Bypass Inc., Primacea, Sadra Medical, TMI/Trireme Inc., and Vascular Therapies Inc., is a board member of VIVA Physicians (not for profit), and is a 501(c) 3 Organization member ( www.vivapvd.com ). C.J.W. is a consultant for Baxter Cellular Therapies and is a member of the PAD Guidelines Task Force (ACC/AHA). He is the CARE Steering committee chair (NCDR/ACC) and president of the Society of Cardiovascular Angiography and Interventions (SCAI). M.C. is on the advisory board of Aastrom Biosciences and Humacyte Inc. P.G. is a scientific advisory board member of Bard/Lutonix and Bayer/Medrad. He is an equity holder and has stock options with Pulse Therapeutics. M.P. has research grants with NHBLI, Johnson and Johnson, Astra Zeneca, Baxter Healthcare, and AHRQ and is a consultant and is on the advisory board of Bayer Healthcare, Baxter, Genzyme, Otsuka, and Cardiostem. K.R. is a consultant for Abbott Vascular, Accelmed, Becker Ventures, Micell, Complete Conference Management, Vortex/AngioDynamics, Endospan, Medicines Company, Shockwave Medical, and VuMedi. He has equity in CardioMEMs, Contego, Endospan, Embolitech, Icon, JanaCare, Medical Simulation Corporation, Micell, Primacea, PQ Bypass, Shockwave Medical, and Vortex. He received research or fellowship support from Abbott Vascular, Cordis, Lutonix/Bard, Atrium, and IDEV Technologies. He is a board member of VIVA Physicians ( www.vivapvd.com ).

PY - 2013/4

Y1 - 2013/4

UR - http://www.scopus.com/inward/record.url?scp=84875246706&partnerID=8YFLogxK

U2 - 10.1016/j.jvir.2012.10.028

DO - 10.1016/j.jvir.2012.10.028

M3 - Article

C2 - 23522155

AN - SCOPUS:84875246706

SN - 1051-0443

VL - 24

SP - 451

EP - 458

JO - Journal of Vascular and Interventional Radiology

JF - Journal of Vascular and Interventional Radiology

IS - 4

ER -

Proceedings from the society of interventional radiology research consensus panel on critical limb ischemia

Access to Document

Other files and links

Cite this